We are live on ! Find out more
HSTO

Histogen Inc. Common Stock
HSTO

Delisted

HSTO was delisted on the 4th of October, 2023.

Back to rankings

22 hedge funds and large institutions have $2.15M invested in Histogen Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

8% less funds holding

Funds holding: 24 → 22 (-2)

28% less capital invested

Capital invested by funds: $2.99M → $2.15M (-$835K)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$58.7K
2
NDSI
Newman Dignan & Sheerar Inc
Rhode Island
+$44.4K
3
VF
Virtu Financial
New York
+$34.6K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$29.3K
5
TSS
Two Sigma Securities
New York
+$24.5K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$101K
2
Citadel Advisors
Citadel Advisors
Florida
-$51.2K
3
Goldman Sachs
Goldman Sachs
New York
-$34K
4
UBS Group
UBS Group
Switzerland
-$9K
5
N
Natixis
France
-$7.7K

HSTO Hedge Fund Activity: Q3 2021 in Review

22 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2021, worth a combined $2.15M — down 28% from $2.99M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of HSTO and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 9 added.

The largest buyer was Northern Trust, adding an estimated $58.7K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $101K sold.

  • 22 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2021, down from 24 in Q2 2021.
  • Funds reported $2.15M of Histogen Inc. Common Stock stock for Q3 2021, down 28% quarter-over-quarter.
  • 4 funds opened new Histogen Inc. Common Stock positions in Q3 2021 and 6 closed out, a net change of -2 holders.
  • The largest Histogen Inc. Common Stock buyer in Q3 2021 was Northern Trust, an estimated $58.7K added.
  • The largest Histogen Inc. Common Stock seller in Q3 2021 was Renaissance Technologies, an estimated $101K sold.

Based on aggregated 13F filings for Q3 2021.